CSG Struggles to Convert €17bn Order Book Into Share Price Momentum

For a defence contractor sitting on a record order backlog and delivering double-digit revenue growth, the stock chart tells a different story. CSG ended the week in Amsterdam at €18.06, a marginal 0.06% dip on the day and a 3.41% weekly loss. The brief midweek bounce – a 2.81% recovery on Thursday – proved insufficient to change the trajectory. The shares have now shed roughly 30% since the end of March.

The fundamental picture remains robust. First-quarter revenue hit €1.544bn, up 13.8% year-on-year, while operating earnings before interest and tax rose 8.7% to €372m, translating into a margin of 24.1%. The order backlog swelled to €17bn, up from €15bn at the close of 2025, with a further €27bn in advanced negotiations. Management reiterated its full-year 2026 guidance and medium-term targets.

The defence systems division – which includes the company's own artillery and tank shell production – outperformed, lifting sales by 26.5% to €1.251bn. CSG now manufactures more than 800,000 such rounds per quarter, underscoring the push to vertical integration.

Yet investors remain unmoved. The stock has surrendered nearly 46% from its 52-week high of €33.81 reached in January. Technical readings show the shares trading well below the 50-day moving average of €20.86; the 200-day line at €26.19 is even further out of reach. The relative strength index of 60.9 points to neutral territory, not oversold.

Should investors sell immediately? Or is it worth buying CSG?

Analysts are split on the near-term outlook but broadly constructive. The consensus from ten analysts remains a buy, with an average price target of €32.45 – more than 44% above the current level. That optimism, however, has been tempered by recent moves. Deutsche Bank trimmed its price target on 26 May, while Jefferies maintained its buy recommendation. Oddo BHF lifted its rating to "outperform" but set a lower target than previously.

The market's scepticism appears to centre on execution rather than strategy. Two key announcements this month failed to generate lasting buying interest. On 22 May, CSG and South Africa's Reunert launched Fuchs Electronics Europe in Slovakia, a joint venture to produce electronic fuses for large-calibre ammunition. CSG holds a 49% stake; Reunert holds 51%. The deal secures a binding offtake agreement for the first three years and establishes an EU production base for fuse technology.

Four days later, CSG signed a cooperation agreement with Polish partner WSK "PZL-KALISZ" covering engines and components for heavy off-road vehicles, spanning both military and civilian automotive use. Financial terms were not disclosed. The company also published an updated investor presentation on 28 May, following the first-quarter release earlier in the month.

CSG at a turning point? This analysis reveals what investors need to know now.

From a technical standpoint, the shares are caught in a narrow band. Support has formed between €17.40 and €17.60, where the price found a floor several times this week. On the upside, resistance sits at €18.92–€19.17, capping any recovery attempts. A break below €17.40 would put the May recovery pattern at risk, while a move above €18.92 would signal renewed buying pressure. Some analysts see a deeper support level at €15.66 if selling intensifies.

The next major catalyst is the half-year report due on 7 August. Until then, the market appears to be in a wait-and-see mode, demanding tangible evidence that the €17bn backlog will convert into cash and earnings rather than further announcements. For a company with strong operational momentum and strategic depth, the price action suggests that promises alone are no longer enough.

Ad

CSG Stock: New Analysis - 30 May

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSG | boerse | 69447727 |